Editorial: Unveiling the Impact of Local or Systemic Therapeutic Strategies on the Tumor Microenvironment.
作者信息
Chen Yun-Wang, Jiang Jia-Hong, Chen Zhe-Ling, Yang Liu
机构信息
Cancer Center, Department of Medical Oncology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, China.
The Medical College, The Qingdao University, Qingdao, China.
出版信息
Front Oncol. 2022 Jan 25;11:832036. doi: 10.3389/fonc.2021.832036. eCollection 2021.
Abstract
摘要
相似文献
1
Editorial: Unveiling the Impact of Local or Systemic Therapeutic Strategies on the Tumor Microenvironment.
Front Oncol. 2022 Jan 25;11:832036. doi: 10.3389/fonc.2021.832036. eCollection 2021.
2
Present and future of cancer immunotherapy: A tumor microenvironmental perspective.
Oncol Lett. 2018 Oct;16(4):4105-4113. doi: 10.3892/ol.2018.9219. Epub 2018 Jul 26.
3
Editorial: Unveiling the tumor microenvironment by machine learning to develop new immunotherapeutic strategies.
Front Immunol. 2023 Aug 15;14:1239648. doi: 10.3389/fimmu.2023.1239648. eCollection 2023.
4
Hypoxia-modulatory nanomaterials to relieve tumor hypoxic microenvironment and enhance immunotherapy: Where do we stand?
Acta Biomater. 2021 Apr 15;125:1-28. doi: 10.1016/j.actbio.2021.02.030. Epub 2021 Feb 24.
5
Cancer immunotherapy: the art of targeting the tumor immune microenvironment.
Cancer Chemother Pharmacol. 2019 Aug;84(2):227-240. doi: 10.1007/s00280-019-03894-3. Epub 2019 Jun 25.
6
Targeting the tumor microenvironment with amphiphilic near-infrared cyanine nanoparticles for potentiated photothermal immunotherapy.
Biomaterials. 2021 Aug;275:120926. doi: 10.1016/j.biomaterials.2021.120926. Epub 2021 Jun 1.
7
Nanoparticles in precision medicine for ovarian cancer: From chemotherapy to immunotherapy.
Int J Pharm. 2020 Dec 15;591:119986. doi: 10.1016/j.ijpharm.2020.119986. Epub 2020 Oct 16.
8
Regulation of cancer-immunity cycle and tumor microenvironment by nanobiomaterials to enhance tumor immunotherapy.
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2020 Jul;12(4):e1612. doi: 10.1002/wnan.1612. Epub 2020 Mar 1.
9
Targeting Immunotherapy to the Tumor Microenvironment.
J Cell Biochem. 2017 Oct;118(10):3049-3054. doi: 10.1002/jcb.26005. Epub 2017 May 15.
10
In situ antitumor vaccination: Targeting the tumor microenvironment.
J Cell Physiol. 2020 Jul;235(7-8):5490-5500. doi: 10.1002/jcp.29551. Epub 2020 Feb 6.
引用本文的文献
1
Enhanced Efficacy against Drug-Resistant Tumors Enabled by Redox-Responsive Mesoporous-Silica-Nanoparticle-Supported Lipid Bilayers as Targeted Delivery Vehicles.
Int J Mol Sci. 2024 May 20;25(10):5553. doi: 10.3390/ijms25105553.
本文引用的文献
1
Conserved pan-cancer microenvironment subtypes predict response to immunotherapy.
Cancer Cell. 2021 Jun 14;39(6):845-865.e7. doi: 10.1016/j.ccell.2021.04.014. Epub 2021 May 20.
2
Metabolic flexibility determines human NK cell functional fate in the tumor microenvironment.
Cell Metab. 2021 Jun 1;33(6):1205-1220.e5. doi: 10.1016/j.cmet.2021.03.023. Epub 2021 Apr 13.
3
Personal neoantigen vaccines induce persistent memory T cell responses and epitope spreading in patients with melanoma.
Nat Med. 2021 Mar;27(3):515-525. doi: 10.1038/s41591-020-01206-4. Epub 2021 Jan 21.
4
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial.
Lancet. 2017 Oct 21;390(10105):1833-1842. doi: 10.1016/S0140-6736(17)32247-X. Epub 2017 Aug 27.
Zotero 插件